PAREXEL International to Present at Leerink Partners Healthcare Conference
February 07 2017 - 1:00PM
Business Wire
PAREXEL International Corporation (NASDAQ: PRXL) announced today
that it will be presenting at the Leerink Partners Healthcare
Conference on Thursday, February 16, 2017, in New York City. Josef
von Rickenbach, Chairman and Chief Executive Officer, will be
making a presentation on PAREXEL and discussing business
developments at 10:30 a.m. ET.
A live webcast of the presentation will be available through the
“Investors” section of PAREXEL’s website at www.PAREXEL.com in the
Upcoming Events portion of the main page, and a replay of the
presentation will be available on the website for 90 days after the
presentation.
About PAREXEL International
PAREXEL International Corporation is a leading global
biopharmaceutical services company, providing a broad range of
expertise-based clinical research, consulting, medical
communications, and technology solutions and services to the
worldwide pharmaceutical, biotechnology and medical device
industries. Committed to providing solutions that expedite
time-to-market and peak-market penetration, PAREXEL has developed
significant expertise across the development and commercialization
continuum, from drug development and regulatory consulting to
clinical pharmacology, clinical trials management, and
reimbursement. PAREXEL Informatics provides advanced technology
solutions, including medical imaging, to facilitate the clinical
development process. Headquartered near Boston, Massachusetts,
PAREXEL has offices in 85 locations in 51 countries around the
world, and had approximately 19,625 employees in the second
quarter. For more information about PAREXEL International visit
www.PAREXEL.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170207006129/en/
PAREXEL InternationalInvestors:Ronald AldridgeEmail:
Ron.Aldridge@PAREXEL.comTel.: + 1-781-434-4753 or
+1-781-434-8465orMedia:Cristi BarnettEmail:
Cristi.Barnett@PAREXEL.comTel.: +1 781-434-4019
Parexel (NASDAQ:PRXL)
Historical Stock Chart
From Mar 2024 to Apr 2024
Parexel (NASDAQ:PRXL)
Historical Stock Chart
From Apr 2023 to Apr 2024